Brooker, S.M.* et al. The spectrum of neurologic phenotypes associated with NUS1 pathogenic variants: A comprehensive case series. Ann. Neurol., DOI: 10.1002/ana.27272 (2025)
Kaymak, A.* et al. Spiking patterns in the globus pallidus highlight convergent neural dynamics across diverse genetic dystonia syndromes. Ann. Neurol., DOI: 10.1002/ana.27185 (2025)
Sorrentino, U.* ; O'Neill, A.G.* ; Kollman, J.M.* ; Jinnah, H.A.* & Zech, M. Purine metabolism and dystonia: Perspectives of a long-promised relationship. Ann. Neurol. 97, 809-825 (2025)
Svorenova, T.* et al. Deep brain stimulation for VPS16-related dystonia: A multicenter study. Ann. Neurol., DOI: 10.1002/ana.27290 (2025)
Blackburn, P.R.* et al. Loss-of-function variants in CUL3 cause a syndromic neurodevelopmental disorder. Ann. Neurol., DOI: 10.1002/ana.27077 (2024)
Harrer, P. et al. Recessive NUP54 variants underlie early-onset dystonia with striatal lesions. Ann. Neurol. 93, 330-335 (2023)
Stenton, S. et al. Leigh syndrome: A study of 209 patients at the Beijing Children's Hospital. Ann. Neurol. 91, 466-482 (2022)
Zech, M. et al. Variants in mitochondrial ATP synthase cause variable neurologic phenotypes. Ann. Neurol. 91, 225-237 (2022)
Musacchio, T.* ; Zech, M. ; Reich, M.M.* ; Winkelmann, J. & Volkmann, J.* A recurrent EIF2AK2 missense variant causes autosomal-dominant isolated dystonia. Ann. Neurol. 89, 1257-1258 (2021)
Schänzer, A.* et al. Mutations in HID1 cause syndromic infantile encephalopathy and hypopituitarism. Ann. Neurol. 90, 143-158 (2021)
Stenton, S. ; Zou, Y.* ; Cheng, H.* ; Prokisch, H. & Fang, F.* Pediatric leigh syndrome: Neuroimaging features and genetic correlations. Ann. Neurol. 88, 218-232 (2021)
Zech, M. ; Steel, D.* ; Kurian, M.A.* & Winkelmann, J. Reply to "Truncating VPS16 mutations are rare in early-onset dystonia". Ann. Neurol. 89:626 (2021)
Steel, D.* et al. Loss-of-function variants in HOPS complex genes VPS16 and VPS41 cause early onset dystonia associated with lysosomal abnormalities. Ann. Neurol. 88, 867-877 (2020)
Tiedt, S.* et al. Circulating metabolites differentiate acute ischemic stroke from stroke mimics. Ann. Neurol. 88, 736-746 (2020)
Tilch, E. et al. Identification of restless legs syndrome genes by mutational load analysis. Ann. Neurol. 87, 184-193 (2020)
Gauthier, J.* et al. Recessive mutations in > VPS13D cause childhood onset movement disorders. Ann. Neurol. 83, 1089-1095 (2018)
Jende, J.M.E.* et al. Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography. Ann. Neurol. 83, 588-598 (2018)
Spadaro, M.* et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann. Neurol. 84, 315-328 (2018)
Maas, R.R.* et al. Progressive deafness–dystonia due to SERAC1 mutations: A study of 67 cases. Ann. Neurol. 82, 1004-1015 (2017)
Escott-Price, V.* et al. Polygenic risk of Parkinson disease is correlated with disease age at onset. Ann. Neurol. 77, 582-591 (2015)
Schirmer, L.* et al. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions. Ann. Neurol. 75, 810-828 (2014)
Buck, D.* et al. Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann. Neurol. 73, 86-94 (2013)
Flinn, L.J.* et al. TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency. Ann. Neurol. 74, 837-847 (2013)
Elstner, M. et al. Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann. Neurol. 66, 792-798 (2009)
Gschwendtner, A.* et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann. Neurol. 65, 531-539 (2009)
Scholz, S.W.* et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol. 65, 610-614 (2009)
Gretarsdottir, S.* & Gieger, C. Risk Variants for Atrial Fibrillation on Chromosome 4q24 Associate with Ischemic Stroke. Ann. Neurol. 64, 402-409 (2008)
Hartig, M.B. et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann. Neurol. 59, 248-256 (2006)
Biskup, S. et al. Common variants of LRRK2 are not associated with sporadic parkinson's disease. Ann. Neurol. 58, 905-908 (2005)
Mueller, J.C. et al. Multiple regions of alpha-synuclein are associated with parkinson's disease. Ann. Neurol. 57, 535-541 (2005)
Asmus, F.* et al. Myoclonus-Dystonia Syndrome : e-Sarcoglycan Mutations and Phenotype. Ann. Neurol. 52, 489-492 (2002)